Agendia Names Medical Advisory Board Chair
Executive Summary
The molecular diagnostics company, Agendia Inc. has appointed Gabriel Hortobagyi chair of its medical advisory board. Currently, Hortobagyi is professor and chair emeritus of the department of breast medical oncology at the MD Anderson Cancer Center (MDACC) and is also the past president of the American Society of Clinical Oncology (ASCO). He is currently the chair of the Southwest Oncology Group Breast Committee and a member of the scientific advisory board of the Breast Cancer Research Foundation.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.